STAAR Surgical Company (STAA) Stock Analysis

STAAR Surgical Company (STAA) is a publicly traded company in the HEALTHCARE sector. It trades at $28.49, carries a market capitalization of $1.47B. This page summarizes the public market data, fundamentals, and frequently asked questions for STAA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NASDAQ

Key Metrics

• Price: $28.49
• Market Cap: $1.47B
• EPS: $-0.42
• 52-Week High: $35.87
• 52-Week Low: $15.59

Market Sentiment

STAAR Surgical Company currently has a Bullish sentiment score of 0.31.

About STAAR Surgical Company

STAAR Surgical Company designs, develops, manufactures, markets and sells implantable eye lenses and supplemental delivery systems for placing the lenses in the eye. The company is headquartered in Lake Forest, California.

GNG Research Analysis

GNG Research scores STAAR Surgical Company (STAA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for STAA.

Frequently Asked Questions

Does STAA pay dividends?

STAAR Surgical Company (STAA) does not currently pay a regular dividend.

What is STAA's market cap?

STAAR Surgical Company (STAA) has a market capitalization of $1.47B with a current stock price of $28.49.